We are live on ! Find out more
CLSD

Clearside Biomedical
CLSD

Delisted

CLSD was delisted on the 28th of November, 2025.

Back to rankings

1 hedge funds and large institutions have $7.87K invested in Clearside Biomedical in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0.52% less ownership

Funds ownership: 0.52% → 0% (-0.52%)

59% less capital invested

Capital invested by funds: $19.1K → $7.87K (-$11.3K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

CLSD Hedge Fund Activity: Q1 2026 in Review

1 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q1 2026, worth a combined $7.87K — down 59% from $19.1K a quarter earlier.

Fund positioning in CLSD was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Clearside Biomedical (CLSD) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $7.87K of Clearside Biomedical stock for Q1 2026, down 59% quarter-over-quarter.
  • 0 funds opened new Clearside Biomedical positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.